Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration

BUZZ-Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration

** Shares of Australia's Amplia Therapeutics ATX.AX rise as much as 37% to A$0.185, hitting their highest level since April 7

** Stock posts its biggest intraday pct gain since March 23

** The pharmaceutical firm signs a clinical trial collaboration and supply agreement with Eli Lilly LLY.N

** Says the deal to test company's experimental cancer drug narmafotinib in combination with Lilly's investigational KRAS inhibitor olomorasib in a clinical trial

** ATX up over 13% this year, including the day's move


(Reporting by Rajasik Mukherjee in Bengaluru)

((Rajasik.Mukherjee@thomsonreuters.com))

Recent news on Amplia Therapeutics

See all news